`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
` ____________
`
`UNIFIED PATENTS, LLC
`Petitioner
`
`v.
`
`MEMORYWEB, LLC
`Patent Owner
`____________
`
`Case No. IPR2021-01413
`Patent 10,621,228
` ____________
`
`
`PETITIONER’S REPLY TO PATENT OWNER’S OPPOSITION TO
`MOTION TO EXCLUDE
`
`
`
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`As Petitioner’s Motion to Exclude (Paper 44) explained, Exhibits 2041, 2042,
`
`
`
`and 2045—which were not cited by Patent Owner or Petitioner in the briefing of this
`
`proceeding—should be excluded. Nothing in Patent Owner’s opposition (Paper 45)
`
`changes this conclusion.
`
`Patent Owner suggests that Petitioner must explain why it is “permitted to
`
`seek relief in the form of a motion to exclude.” Paper 45, 3. However, no explanation
`
`is needed; no prior authorization is required for motions to exclude, which are
`
`different from motions to strike. See Scheduling Order (Paper 16), 10 (“Either party
`
`may file a motion to exclude evidence (37 C.F.R. § 42.64(c))”). Further, while
`
`Petitioner was authorized a sur-sur reply to respond to portions of the sur-reply
`
`relying on Exhibits 2043 and 2044 (not subject to this motion), Petitioner could not
`
`respond to Exhibits 2041, 2042, and 2045 because Patent Owner never cited to them
`
`or Dr. Bederson’s testimony about them in its sur-reply. These exhibits should be
`
`excluded, at least to preclude new arguments during the hearing.
`
`I. PETITIONER’S MOTION TO EXCLUDE IS PROPER
`
`Patent Owner states that in view of the Trial Practice Guide (“TPG”) and
`
`Ascend Performance Operations LLC v. Samsung SDI Co. (IPR2020-00349)
`
`(“Ascend”), the relief Petitioner requested in its Motion to Exclude is improper
`1
`
`
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`because it should have been brought via a Motion to Strike. Paper 45, 2-3. Patent
`
`Owner conflates the two motions. Motions to Exclude are the correct avenue to
`
`address evidence filed (including evidence filed but not cited) with a Patent Owner’s
`
`sur-reply pursuant to 37 C.F.R. § 42.23(b). See, e.g., Netflix v. Divx, IPR2020-00511,
`
`Paper 46, 54-56 (PTAB Aug. 13, 2021); Netflix, Inc. v. DivX, LLC, IPR2020-00558,
`
`Paper 50, 32-36 (PTAB Aug. 23, 2021; Intel Corp. v. Parkervision, Inc., IPR2020-
`
`01265, Paper 44, 74-75 (PTAB Jan. 21, 2022); Hamilton Techs. LLC v. Fleur
`
`Tehrani, IPR2020-01199, Paper 57, 51-54 (PTAB Dec. 28, 2021) (all cases granting
`
`Motions to Exclude evidence filed with a Patent Owner’s sur-reply pursuant to 37
`
`C.F.R. § 42.23(b)).
`
`II.
`
`37 C.F.R. § 42.23(b) MANDATES EXCLUSION
`
`Patent Owner relies on Edwards Lifesciences Corp. v. Cardiovalve Ltd.
`
`(IPR2021-00383) (“Edwards”) and Ascend to assert the Board “has not always
`
`applied Rule 42.23(b) in the manner suggested by Petitioner” and “has allowed
`
`exhibits ‘used during cross-examination…for the limited purpose of allowing the
`
`Board to understand the context of the cross-examination.’” Paper 45, 3-4. This
`
`reliance is misplaced for at least two reasons.
`
`
`
`2
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`First, unlike in Edwards and Ascend, neither Dr. Bederson testimony related
`
`to Exhibits 2041, 2042, and 2045, nor the exhibits themselves were ever cited in the
`
`sur-reply. Edwards, IPR2021-00383, Paper 39, 1; Ascend, IPR2020-00349, Paper
`
`38, 10. This is exactly the kind of scenario to which § 42.23(b) applies.
`
`Second, Exhibits 2041, 2042, and 2045 do not provide the Board with
`
`understanding of the context of Dr. Bederson’s cross examination testimony because
`
`during Dr. Bederson’s reply deposition, where these exhibits were first introduced
`
`by Patent Owner, he testified that he had not seen these exhibits before in this
`
`proceeding and was not familiar with them. EX2046, 190:3-12; see Netflix,
`
`IPR2020-00511, Paper 46, 52–55 (granting motion to exclude, finding exhibits did
`
`not provide context as the declarant testified he had not seen them before); see also
`
`Netflix, IPR2020-00558, Paper 50, 32-36. Edwards and Ascend are distinguishable
`
`because in those proceedings no such testimony regarding the declarant’s knowledge
`
`of the exhibits at issue was brought to the Board’s attention. Edwards, Paper 39;
`
`Ascend, Paper 38, Paper 47. Exhibits 2041, 2042, and 2045 were not reliable to test
`
`Dr. Bederson’s opinions and, therefore, should be excluded.
`
`
`
`
`
`3
`
`
`
`III. PETITIONER FACES UNDUE PREJUDICE
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`
`Patent Owner states “Petitioner can hardly claim prejudice here” because it
`
`was authorized and filed a sur-sur reply to address portions of Patent Owner’s sur-
`
`reply that relied on Exhibits 2043 and 2044, those of Exhibits 2041-2045 that Patent
`
`Owner relied on in its sur-reply. Paper 45, 5; Paper 42, 1-5. But Patent Owner’s
`
`statement is belied by another part of its opposition, which asserts for the first time
`
`in this proceeding that exhibits 2041, 2042, 2045—exhibits Petitioner could not
`
`address in its sur-sur reply because they were not relied on by Patent Owner in Patent
`
`Owner’s sur-reply—are “relevant to claim construction” regarding “disputed claim
`
`terms” and reflect on Dr. Bederson.1 Paper 45, 5-6. By not having the opportunity to
`
`
`
` Exhibit 2045, a patent that issued over a year ago listing Dr. Bederson as an
`
` 1
`
`inventor, is irrelevant to this proceeding. Patent Owner disingenuously states Dr.
`
`Bederson “was unable to respond substantively because he hadn’t ‘even read the
`
`claim’” of the patent. Paper 45, 6; EX2046, 79:18-80:2, 81:9-11. But Dr. Bederson
`
`testified that Exhibit 2045 was “not something that I have read in many years and I
`
`have not considered this claim in a long time.” EX2046, 88:15-19, 90:3-5.
`
`
`
`4
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`address exhibits 2041, 2042, and 2045 or Dr. Bederson’s deposition testimony
`
`associated with them, Petitioner faces undue prejudice. Patent Owner had every
`
`opportunity to (1) question Dr. Bederson regarding these exhibits during his first
`
`deposition, (2) file these exhibits with its Patent Owner’s Response and substantively
`
`discuss them there, or (3) substantively discuss these exhibits in its sur-reply, in
`
`which case Petitioner would have at least had the possibility of addressing them in
`
`the sur-sur reply. Patent Owner did none of this and instead raised new arguments
`
`about them for the first time in its opposition. Paper 45, 5-6.
`
`Exhibits 2041, 2042, and 2045 should be excluded to prevent Patent Owner
`
`from presenting its improper new arguments. Allowing Exhibits 2041, 2042, and
`
`2045 to bear on this proceeding would allow Patent Owner to have raised
`
`“completely new evidence during a deposition” and “introduce that evidence into
`
`the record with a sur-reply,” which “depriv[][es]” Petitioner “the opportunity to fully
`
`address that evidence,” the very situation Ascend sought to avoid. IPR2020-00349,
`
`Paper 53, 12. Thus, Petitioner faces undue prejudice if Exhibits 2041, 2042, and
`
`2045 are not excluded.
`
`
`
`5
`
`
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`IV. EXHIBITS 2041, 2042, AND 2045 SHOULD BE EXCLUDED UNDER
`THE FEDERAL RULES OF EVIDENCE (“FRE”) 401-403
`
`As explained, Exhibits 2041, 2042, and 2045 do not provide context for Dr.
`
`Bederson’s testimony and are not relied upon, even indirectly, in the parties’ briefs.
`
`Supra, 3. Accordingly, these exhibits are irrelevant and should be excluded under
`
`FRE 401-403. And Patent Owner’s statement that “the Board rarely excludes
`
`exhibits under FRE 401-403” is undercut by Ascend, which granted a motion to
`
`exclude exhibits which were “never relied upon.” Ascend, IPR2020-00349, Paper
`
`53, 13 (PTAB July 15, 2021); see also SK Innovation Co.., Ltd., v. Celgard, LLC,
`
`IPR2014-00679, Paper 58, 49 (PTAB Sept. 25, 2015) (excluding exhibits that Patent
`
`Owner did not rely on as irrelevant under FRE 401 and 402); Shimano Inc., v.
`
`Globeride, Inc., IPR2015-00273, Paper 40, 27-28 (PTAB June 16, 2016).
`
`V. CONCLUSION
`
`For at least the foregoing reasons, Exhibits 2041, 2042, and 2045 should be
`
`
`
`excluded.
`
`
`
`
`
`
`
`Date: December 6, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Ellyar Y. Barazesh/
`Ellyar Y. Barazesh
`Reg. No. 74,096
`Counsel for Petitioner
`
`6
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2021-01413
`U.S. Patent 10,621,228
`
`
`The undersigned hereby certifies
`
`that a copy of
`
`the
`
`foregoing
`
`
`
`
`PETITIONER’S REPLY TO PATENT OWNER’S OPPOSITION TO MOTION
`
`TO EXCLUDE was served on December 6, 2022, via electronic mail, as agreed to
`
`by counsel, upon the following counsel for Patent Owner:
`
`
`
`Jennifer Hayes
`Nixon Peabody LLP
`300 South Grand Avenue, Suite 4100
`Los Angeles, CA 90071-3151
`jenhayes@nixonpeabody.com
`
`George Dandalides
`Nixon Peabody LLP
`70 West Madison, Suite 5200
`Chicago, IL 60602-4224
`gdandalides@nixonpeabody.com
`
`Matthew A. Werber
`Nixon Peabody LLP
`70 West Madison, Suite 5200
`Chicago, IL 60602-4224
`mwerber@nixonpeabody.com
`
`
`
`Date: December 6, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Ashley F. Cheung/
`Ashley F. Cheung
`Paralegal
`Unified Patents, LLC
`
`
`
`
`
`